306
Views
0
CrossRef citations to date
0
Altmetric
Review Articles

Nanocrystals based mucosal delivery system: research advances

, , , , &
Pages 1700-1712 | Received 24 Oct 2021, Accepted 07 Mar 2022, Published online: 25 Mar 2022

References

  • Müller RH, Gohla S, Keck CM. State of the art of nanocrystals-special features, production, nanotoxicology aspects and intracellular delivery. Eur J Pharm Biopharm. 2011;78(1):1–9.
  • Ghosal K, Augustine R, Zaszczynska A, et al. Novel drug delivery systems based on triaxial electrospinning based nan-ofibers. React Funct Polym. 2021;163(1):104895.
  • Liu Y, Wang L, Zhao Y, et al. Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin. Int J Pharm. 2014;476(1–2):169–177.
  • Ghosal K, Adak S, Agatemor C, et al. Novel interpenetrating polymeric network based microbeads for delivery of poorly water soluble drug. J Polym Res. 2020;27(4):98.
  • Biswas A, Mondal S, Das SK, et al. Development and characterization of natural product derived macromolecules based Interpenetrating Polymer Network for Therapeutic Drug Targeting. ACS Omega. 2021;6(43):28699–28709.
  • Pal A, Roy S, Kumar A, et al. Physicochemical characterization, molecular docking, and in vitro dissolution of Glimepiride-Captisol Inclusion Complexes. ACS Omega. 2020;5(32):19968–19977.
  • Aloisio C, Antimisiaris SG, Longhi MR. Liposomes containing cyclodextrins or meglumine to solubilize and improve the bioavailability of poorly soluble drugs. J Mol Liq. 2017;229:106–113.
  • Du X, Hou Y, Huang J, et al. Cytosolic delivery of the immunological adjuvant poly I:C and cytotoxic drug crystals via a carrier-free strategy significantly amplifies immune response. Acta Pharm Sin B. 2021;11(10):3272–3285.
  • Teng C, Li B, Lin C, et al. Targeted delivery of baicalein-p53 complex to smooth muscle cells reverses pulmonary hypertension. J Control Release. 2022;341:591–604.
  • Wang X, Mohammad IS, Fan L, et al. Delivery strategies of amphotericin B for invasive fungal infections. Acta Pharm Sin B. 2021;11(8):2585–2604.
  • Xia D, Gan Y, Cui F. Application of precipitation methods for the production of water-insoluble drug nanocrystals: production techniques and stability of nanocrystals. CPD. 2014;20(3):408–435.
  • Zhang J, Lv H, Jiang K, et al. Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal. Int J Pharm. 2011;420(1):180–188.
  • Xie Y, Xu J, Chen Y, et al. A progress and thinking on the application of nanocrystals technology to poorly soluble drugs. Modern Tradit Chin Med Mater Med World Sci Technol. 2016;18:1788–1793.
  • Bandi SP, Bhatnagar S, Venuganti VVK. Advanced materials for drug delivery across mucosal barriers. Acta Biomater. 2021;119:13–29.
  • Wang S, Gao Z, Liu L, et al. Preparation, in vitro and in vivo evaluation of chitosan-sodium alginate-ethyl cellulose polyelectrolyte film as a novel buccal mucosal delivery vehicle. Eur J Pharm Sci. 2022;168:106085.
  • Yue P, Liu Y, Xie J, et al. Review and prospect on preparation technology of drug nanocrystals in the past thirty years. Acta Pharm Sin. 2018;53:529–537.
  • Lu Y, Li Y, Wu W. Injected nanocrystals for targeted drug delivery. Acta Pharm Sin B. 2016;6(2):106–113.
  • Yue P, Yong W, Wan J, et al. The research progress of preparation methods of solid nanocrystal delivery system. Yao Xue Xue Bao. 2012;47(9):1120–1127.
  • Zuo J, Shen C, Shen B, et al. Preparation and in vitro anti-hepatic fibrosis evaluation of herpetone nanosuspensions. Zhongguo Zhong Yao Za Zhi. 2019;44(6):1164–1169.
  • Zhang M, Yao HE. Preparation and quality evaluation of norcantharidin nanosuspensions. J Int Pharm Res. 2019;46:211–217.
  • Li Z, Jiang X, Yao Z, et al. Chitosan functionalized cellulose nanocrystals for stabilizing pickering emulsion: fabrication, characterization and stability evaluation. Colloids Surf A. 2022;632:127769.
  • Zhang J, Wu L, Chan HK, et al. Formation, characterization, and fate of inhaled drug nanoparticles. Adv Drug Deliv Rev. 2011;63(6):441–455.
  • Liu T, Yu X, Yin H. Study of top-down and bottom-up approaches by using design of experiment (DoE) to produce meloxi-cam nanocrystal capsules. AAPS PharmSciTech. 2020;21(3):79.
  • Zhang Y, Yu H, Huang T. Preparation and in vivo pharmacokinetic study of rhubaric acid nano suspension. Chin Pat Med. 2020;42:2829–2834.
  • Pei Y, Yan C, Niu M, et al. Preparation and in vivo pharmacokinetic behavior of naringin nanoscale suspension. Chin Pat Med. 2019;41:2034–2038.
  • Keck CM. Nanocrystals and amorphous nanoparticles and method for production of the same by a low energy process: US, 11185527 [P]. 2011;10–17.
  • Scholz P, Arntjen A, Müller RH, et al. ARTcrystal process for industrial nanocrystal production-optimization of the ART MICCRA pre-milling step. Int J Pharm. 2014;465(1–2):388–395.
  • Scholz P, Keck CM. Flavonoid nanocrystals produced by ARTcrystal®-technology. Int J Pharm. 2015;482(1–2):27–37.
  • Gao Y, Wang J, Wang Y, et al. Crystallization methods for preparation of nanocrystals for drug delivery system. Curr Pharm Des. 2015;21:3131–3139.
  • Liu G, Li S, Huang Y, et al. Incorporation of 10-hydroxycamptothecin nanocrystals into zein microspheres. Chem Eng Sci. 2016;155:405–414.
  • Zhang J, Huang Y, Liu D, et al. Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement. Eur J Pharm Sci. 2013;48(4–5):740–747.
  • Wang J, Ju X. Preparation and characterization of naringin nanosuspension. Chin J Hosp Pharm. 2020;40:1212–1216.
  • Zou Q, Tan W, Ning Q, et al. Preparation and quality evaluation of magnolol nanocrystal suspension. China Pharm. 2019;30:2037–2041.
  • Wang W, Zhao N, Luan L, et al. Studies on preparation of silybin nanosuspension & its pharmacokinetics in rats. Antiinfect Pharm. 2009;6:153–157.
  • Jakubowska E, Lulek J. The application of freeze-drying as a production method of drug nanocrystals and solid dispersions–a review. J Drug Delivery Sci Technol. 2021;62:102357.
  • Zhang C, Ding Y, Yang Y, et al. The preparation and antioxidant in vitro of resveratrol nanocrystal. Chin J Pharm (Online Ed). 2019;17:157–168.
  • Zhou Y, Fang Q, Niu B, et al. Comparative studies on amphotericin B nanosuspensions prepared by a high pressure homogenization method and an antisolvent precipitation method. Colloids Surf B Biointerfaces. 2018;172:372–379.
  • Hao X, Gao Y, Wang X. Preparation, characterization, and anti-4T1-tumor efficacy of quercetin nanoparticles. Chin Tradit Herbal Drugs. 2019;50:42–51.
  • Xie Y, Yu T, Lou W. Preparation and assessment of the antitumor effect of ginsenoside Rg3 nanocrystals. Herald Med. 2016;35:1186–1189.
  • Yue P, Li Y, Wan J, et al. Process optimization and evaluation of novel baicalin solid nanocrystals. Int J Nanomed. 2013;8:2961–2973.
  • Liu T, Müller RH, Möschwitzer JP. Systematical investigation of a combinative particle size reduction technology for production of resveratrol nanosus-pensions. AAPS PharmSciTech. 2017;18(5):1683–1691.
  • Salazar J, Müller RH, Möschwitzer JP. Performance comparison of two novel combinative particle-size-reduction technologies. J Pharm Sci. 2013;102(5):1636–1649.
  • Shaal LA, Shegokar R, Müller RH. Production and characterization of antioxidant apigenin nanocrystals as a novel UV skin protective formulation. Int J Pharm. 2011;420(1):133–140.
  • Li Y, Teng C, Azevedo HS, et al. Cocrystallization-like strategy for the codelivery of hydrophobic and hydrophilic drugs in a single carrier material formulation. Chin Chem Lett. 2021;32(10):3071–3075.
  • Gera S, Talluri S, Rangaraj N, et al. Formulation and evaluation of naringenin nanosuspensions for bioavailability enhancement. AAPS PharmSciTech. 2017;18(8):3151–3162.
  • Shim S, Yoo HS. The application of mucoadhesive chitosan nanoparticles in nasal drug delivery. Mar Drugs. 2020;18(12):605.
  • Liuzzi R, Carciati A, Guido S, et al. Transport efficiency in transdermal drug delivery: what is the role of fluid microstructure? Colloids Surf B Biointerfaces. 2016;139:294–305.
  • McCright JC, Maisel K. Engineering drug delivery systems to overcome mucosal barriers for immunotherapy and vaccination. Tissue Barriers. 2020;8(1):1695476.
  • Sharma OP, Patel V, Mehta T. Nanocrystal for ocular drug delivery: hope or hype. Drug Deliv Transl Res. 2016;6(4):399–413.
  • Kumar M, Jha A, Dr M, et al. Targeted drug nanocrystals for pulmonary delivery: a potential strategy for lung cancer therapy. Expert Opin Drug Deliv. 2020;17(10):1459–1472.
  • Zeb A, Arif ST, Malik M, et al. Potential of nanoparticulate carriers for improved drug delivery via skin. J Pharm Investig. 2019;49(5):485–517.
  • Wong TW, Harjoh N, Nawaz A, et al. Nanocarriers and their actions to improve skin permeability and transdermal drug delivery. CPD. 2015;21(20):2848–2866.
  • Shi T, Lv Y, Huang W, et al. Enhanced transdermal delivery of curcumin nanosuspensions: a mechanistic study based on co-localization of particle and drug signals. Int J Pharm. 2020;588:119737.
  • Chen Z. Study on percutaneous delivery system of polydatin soluble microneedle. Guangdong: Guangdong Pharmaceutical University; 2020.
  • Qin F, Yu J, Ji Z, et al. Study on preparation and in vitro transdermal penetration of nanosuspension-based gel of ursolic acid. J Guangdong Pharm Univ. 2017;33:285–289.
  • Shen C, Shen B, Xu P, et al. Preparation of nanosuspension-based gel of Ganoderma lucidum triterpenoids and its in vitro transdermal diffusion characteristics. Chin Tradit Herbal Drugs. 2014;45:2770–2775.
  • Abdelghany S, Tekko IA, Vora L, et al. Nanosuspension-based dissolving microneedle arrays for intradermal delivery of curcumin. Pharmaceutics. 2019;11(7):308.
  • Yang L, Jia M, Zhen Y. Research progress of nasal drug delivery system. Northwest Defense Med J. 2016;37:671–673.
  • Pardeshi CV, Belgamwar VS. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting . Expert Opin Drug Deliv. 2013;10(7):957–972.
  • Fan H, Gu F. Research and clinical application progress of new dosage form for nasal delivery. West China Pharm J. 2018;33:548–554.
  • Wu C, Li B, Zhang Y, et al. Intranasal delivery of paeoniflorin nanocrystals for brain targeting. Asian J Pharm Sci. 2020;15(3):326–335.
  • Hao J. Study on improving oral bioavailability of resveratrol nanoscale suspension and transnasal brain targeted drug deliv-ery system. Shandong: Shandong University; 2015.
  • Latif R, Makar RR, Hosni EA, et al. The potential of intranasal delivery of nanocrystals in powder form on the improvement of zaleplon performance: in-vitro, in-vivo assessment. Drug Dev Ind Pharm. 2021;47(2):268–279.
  • Wang S, Wang X, Cui X, et al. Progress of nano-controlled releasing system on ophthalmologic administration. Int J Ophthalmol. 2015;15:2094–2098.
  • Ali H, York P, Ali A, et al. Hydrocortisone nanosuspensions for ophthalmic delivery: a comparative study between microfluidic nanoprecipita-tion and wet milling. Control Release. 2011;149(2):175–181.
  • Patravale VB, Date AA, Kulkarni RM. Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol. 2010;56(7):827–840.
  • Zhang Q. Preparation and evaluation of baicalin nanocrystalline ocular in situ gel. Ningxia: Ningxia Medical University. 2014.
  • Li X, Liu Y, Zhang P, et al. Therapeutical effect of nanosuspension-based gel of curcumin on selenium-induced cataract in rats. Chin J Exper Tradit Med Formulae. 2017;23:9–13.
  • Kim JH, Sun WJ, Sang DH, et al. Development of a novel ophthalmic ciclosporin A-loaded nanosuspension using top-down media milling methods. Pharmazie. 2011;66(7):491–495.
  • Liu D, Wan B, Qi J, et al. Permeation into but not across the cornea: bioimaging of intact nanoemulsions and nanosuspen-sions using aggregation-caused quenching probes. Chin Chem Lett. 2018;29(12):1834–1838.
  • Hua S. Advances in nanoparticulate drug delivery approaches for sublingual and buccal administration. Front Pharmacol. 2019;10:1328.
  • Alaei S, Omidian H. Mucoadhesion and mechanical assessment of oral films. Eur J Pharm Sci. 2021; 159:105727.
  • Chang D, Ma Y, Cao G, et al. Improved oral bioavailability for lutein by nanocrystal technology: formulation development, in vitro and in vivo evaluation. Artif Cells Nanomed Biotechnol. 2018;46(5):1018–1024.
  • Liu X. Study on the construction and evaluation of quercetin nano suspension rapid oral drug delivery system. Chengdu: Chengdu University of Traditional Chinese Medicine; 2018.
  • Gill S, Löbenberg R, Ku T, et al. Nanoparticles: characteristics, mechanisms of action, and toxicity in pulmonary drug delivery—a review. J Biomed Nanotechnol. 2007;3(2):107–119.
  • Liu Q, Guan J, Sun Z. Influence of stabilizer type and concentration on the lung deposition and retention of resveratrol nanosuspen-sion-in-microparticles. Int J Pharmaceut. 2019;569:118562.
  • Huang H, Miao M, Bai M, et al. Analysis of efficacy mechanism of oral, nasal, ear and eye, rectal, umbilical and skin medication in chinese medicine. J Hunan Univ Chin Med. 2019;39(10):1285–1288.
  • Li F, Tian J, Wang J, et al. Research progress of rectal drug delivery system. Chin Pat Med. 2019;41:1115–1118.
  • Kansom T, Sajomsang W, Saeeng R, et al. Fabrication and characterization of andrographolide analogue (3A.1) nanosuspensions stabilized by amphiphilic chi-tosan derivatives for colorectal cancer therapy. J Drug Delivery Sci Technol. 2019;54:101287.
  • Carvalho GC, Araujo VHS, Fonseca-Santos B, et al. Highlights in poloxamer-based drug delivery systems as strategy at local application for vaginal infections. Int J Pharm. 2021;602:120635.
  • Ho HM, Huang CY, Cheng YJ, et al. Squalene nanoemulsion reinforces mucosal and immunological fingerprints following intravaginal delivery. Biomed Pharmacother. 2021;141:111799.
  • Pandit A, Kedar A, Koyate K. Hollow pessary loaded with lawsone via self-microemulsifying drug delivery system for vaginal candidiasis. J Drug Delivery Sci Technol. 2020;60:101955.
  • Lv F, Wang J, Chen H, et al. Enhanced mucosal penetration and efficient inhibition efficacy against cervical cancer of PEGylated docetaxel nanocrystals by TAT modification. J Control Release. 2021;336:572–582.
  • Gong T, Patel SK, Parniak MA, et al. Nanocrystal formulation improves vaginal delivery of CSIC for HIV prevention. AAPS PharmSciTech. 2019;20(7):286.
  • Parmar PK, Wadhawan J, Bansal AK. Pharmaceutical nanocrystals: a promising approach for improved topical drug delivery. Drug Discov Today. 2021;26(10):2329–2349.
  • Li Y, Wang D, Lu S, et al. Pramipexole nanocrystals for transdermal permeation: characterization and its enhancement micro-mechanism. Eur J Pharm Sci. 2018;124:80–88.
  • Mudgil M, Pawar PK. Preparation and in vitro/ex vivo evaluation of moxifloxacin-loaded PLGA nanosuspensions for ophthalmic application. Sci Pharm. 2013;81(2):591–606.
  • Luo C. Preparation and in vitro dissolution of ziprasidone nanoscale suspension membranes. West China Pharm J. 2019;34:468–474.
  • Ding Y, Kang B, Wang J. Preparation and in vitro evaluation of budesonide inhalation nanosuspension. Chin J Pharm. 2017;48:1131–1137.
  • Oshi MA, Lee J, Naeem M, et al. Curcumin nanocrystal/pH-responsive polyelectrolyte multilayer core-shell nanoparticles for inflammation-targeted alleviation of ulcerative colitis. Biomacromolecules. 2020;21(9):3571–3581.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.